COMMUNIQUÉS West-GlobeNewswire

International Endeavors Excited About California Marijuana Legalization
04/01/2018
TEMECULA, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE — International Endeavors Corp (OTC:IDVV) is pleased to announce the following: The arrival of 2018 in California brought with it broad legalization of [...]
EyeGate Promotes Sarah Romano to Chief Financial Officer
04/01/2018
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]
American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In California
04/01/2018
DENVER, CO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis [...]
PTS Diagnostics Announces New Retail Point-of-Care Software
04/01/2018
PTS Connect ProLink ® platform expands connectivity and informatics offerings INDIANAPOLIS, Jan. 04, 2018 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.-based manufacturer of point-of-care biometric testing devices, today [...]
Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum
04/01/2018
Pittsburgh, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]
GTX Corp and Veristride Presenting Biometric Insoles at CES 2018
04/01/2018
LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced today that [...]
Allscripts to release fourth-quarter and full-year 2017 financial results February 15
04/01/2018
CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq: MDRX ) will report its financial results for the three months and full year ended December 31, 2017, after the close of stock [...]
Catalyst Biosciences Initiates Phase 2/3 Trial of Marzeptacog Alfa (activated) for Prophylaxis in Hemophilia A or B with Inhibitors
04/01/2018
Currently Enrolling Individuals with Hemophilia A or B with Inhibitors Interim Data Expected During the First Half of 2018 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. ( [...]
Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year
04/01/2018
Long Term Data on FMX-101 in Moderate-to-Severe Acne to be Presented at Winter Clinical Dermatology Conference (January 12 th -17 th ) REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Foamix [...]
Celtaxsys Secures Private Financing to Advance Acebilustat Phase 3 Cystic Fibrosis (CF) Program Preparatory Activities
04/01/2018
ATLANTA, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for rare inflammatory diseases, today announced the successful completion of a [...]
aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Cellectar Biosciences to Participate at Biotech Showcase 2018
04/01/2018
MADISON, Wis., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Tyme Announces Presentation of Clinical Data on SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium
04/01/2018
Mack Roach, M.D., FASCO , University of California, San Francisco, to present data from ongoing Phase II clinical trial NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq: TYME ), a clinical- [...]
HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance
04/01/2018
Fourth quarter 2017 revenue expected to be between $6.9 and $7.2 million Full year 2017 revenue expected to be between $13.8 and $14.1 million Initial full year 2018 revenue guidance of $20.0 to $25.0 million TUCSON, [...]
Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity
04/01/2018
- Final protocol confirmed for pivotal Phase 3 clinical trial in pro-opiomelanocortin (POMC) deficiency obesity - - Setmelanotide granted Orphan Drug Designation for treatment of leptin receptor (LEPR) deficiency [...]
Paul Stead Joins Adaptimmune as Vice President of Business Development
04/01/2018
PHILADELPHIA, Pa. and OXFORD, England, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today announced that Paul Stead, B. Pharm, PhD, MBA, MR [...]
Newly Published Journal of Antimicrobial Chemotherapy Supplement Provides Insights into the Future of Echinocandin Therapy for Invasive Fungal Infections
04/01/2018
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that a new compendium of papers [...]
Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed Stage III/IV Ovarian Cancer
04/01/2018
GEN-1 to Enter the Clinic in Mid-2018 Following a Phase IB Trial Which Demonstrated 100% Disease Control, 86% Objective Response Rate and 86% R0 & R1 Surgical Resection Rate in All Patients Treated Compelling [...]
Stemline Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
04/01/2018
NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers announced today that Ivan [...]

Pages